<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02474680</url>
  </required_header>
  <id_info>
    <org_study_id>AIHG-1420-PGxTIME</org_study_id>
    <nct_id>NCT02474680</nct_id>
  </id_info>
  <brief_title>Evaluation of Pharmacogenetic Testing In a Mental Health Population and Economic Outcomes</brief_title>
  <acronym>PGx-TIME</acronym>
  <official_title>Evaluation of Pharmacogenetic Testing In a Mental Health Population and Economic Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Avera McKennan Hospital &amp; University Health Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Avera McKennan Hospital &amp; University Health Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a non-randomized, single-case design of pharmacogenetic implementation in a mental
      health patient population of subjects taking antipsychotics and/or antidepressants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a non-randomized, single-case design of pharmacogenetic implementation in a mental
      health patient population of subjects taking antipsychotics and/or antidepressants.
      Retrospective and prospective data will be collected on all subjects before and after
      pharmacogenetic recommendations have been made. Retrospective data will be collected for the
      previous 12 months before pharmacogenetic recommendations are made and prospective data will
      be collected for 12 months after pharmacogenomic recommendations have been made.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2015</start_date>
  <completion_date type="Actual">January 1, 2017</completion_date>
  <primary_completion_date type="Actual">January 1, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Depression scores</measure>
    <time_frame>12 months</time_frame>
    <description>Compare depression scores at baseline and following pharmacogenetic-guided medication recommendation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Economic impact of pharmacogenetic testing</measure>
    <time_frame>12 months</time_frame>
    <description>Data from patients' insurance provider will be compared pre- and post-pharmacogenetic testing. Such data may include hospitalizations, clinic visits, ER visits, medication expenses, etc.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">84</enrollment>
  <condition>Major Depressive Disorder 1</condition>
  <arm_group>
    <arm_group_label>Care Coordination Group</arm_group_label>
    <description>Patients participating in the Avera Care Coordination Program for Intervention 'Pharmacogenetic testing'</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Pharmacogenetic testing</intervention_name>
    <description>Psychotropic genotyping panel</description>
    <arm_group_label>Care Coordination Group</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Participants must be enrolled in the Avera Care Coordination Program and have insurance
        coverage through the Avera Health Plans
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Must be taking either an anti-depressant or an anti-psychotic medication

          -  Must provide informed consent

          -  Must have Avera Health Plans insurance coverage

          -  Must have three months of participation in the Avera Care Coordination Program

        Exclusion Criteria:

          -  Must not be pregnant or breastfeeding

          -  Must not have an active and/or unstable diagnosis of substance abuse

          -  Must not have a primary diagnosis of dementia, bulimia, or anorexia nervosa disorder

          -  Must not have had a previous pharmacogenetic evaluation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthew Stanely, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Avera McKennan Hospital &amp; University Health Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Avera Institute for Human Genetics</name>
      <address>
        <city>Sioux Falls</city>
        <state>South Dakota</state>
        <zip>57108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.avera-research.org</url>
    <description>Avera Institute for Human Genetics</description>
  </link>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 5, 2015</study_first_submitted>
  <study_first_submitted_qc>June 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 18, 2015</study_first_posted>
  <last_update_submitted>May 2, 2017</last_update_submitted>
  <last_update_submitted_qc>May 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>depression</keyword>
  <keyword>Major Depressive Disorder</keyword>
  <keyword>MDD</keyword>
  <keyword>mental health</keyword>
  <keyword>pharmacogenomics</keyword>
  <keyword>personalized medicine</keyword>
  <keyword>precision medicine</keyword>
  <keyword>anti-depressants</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

